Free Trial

Trinity Biotech (TRIB) SEC Filings & 10K Form

$1.69
+0.06 (+3.68%)
(As of 05/24/2024 ET)

Recent Trinity Biotech SEC Filings

DateFilerForm TypeView
05/16/2024
12:15 PM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/07/2024
11:15 PM
Trinity Biotech (Filer)
Form EFFECT
05/07/2024
3:25 PM
Trinity Biotech (Filer)
Form 424B3
04/30/2024
4:14 PM
Trinity Biotech (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
04/30/2024
2:48 PM
Trinity Biotech (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
04/30/2024
11:28 AM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/05/2024
12:05 PM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/15/2024
1:11 PM
Trinity Biotech (Filer)
Form 424B3
02/09/2024
6:51 PM
PERCEPTIVE ADVISORS LLC (Filed by)
Trinity Biotech (Subject)
Form SC 13D
02/01/2024
10:33 AM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/01/2024
10:37 AM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/02/2024
3:17 PM
MiCo IVD Holdings, LLC (Filed by)
Trinity Biotech (Subject)
Form SC 13D/A
01/02/2024
3:13 PM
MiCo Co., Ltd. (Filed by)
Trinity Biotech (Subject)
Form SC 13D/A
01/02/2024
1:02 PM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/19/2023
12:56 PM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/29/2023
8:00 AM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/06/2023
3:05 PM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/12/2023
3:04 PM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/05/2023
2:38 PM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/10/2023
5:02 AM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:TRIB) was last updated on 5/26/2024 by MarketBeat.com Staff

From Our Partners